Sean Ainsworth
Director/Board Member at OCUPHIRE PHARMA, INC.
Net worth: 148 441 $ as of 31/05/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Cam Gallagher | M | 54 |
Immusoft Corp.
 Immusoft Corp. Medical/Nursing ServicesHealth Services Immusoft Corp. provides disease curing services through immune cells. The firm offers ISP, gene delivery technology and lymphopoiesis culture system. The company was founded by Matthew Scholz in 2009 and is headquartered in Seattle, WA.
RetroSense Therapeutics LLC
 RetroSense Therapeutics LLC Medical SpecialtiesHealth Technology RetroSense Therapeutics LLC provides biotechnology services. It offers gene therapies to restore vision in patients suffering from blindness due to retinitis pigmentosa and advanced dry age-related macular degeneration. The company was founded by Sean Ainsworth in 2009 and is headquartered in Ann Arbor, MI.
Ray Therapeutics, Inc.
 Ray Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Ray Therapeutics, Inc. is an American company that is developing a lead candidate, RTX-015, to treat retinitis pigmentosa, a degenerative retinal disease. Ray Therapeutics is based in an undisclosed location. The company's mission is to restore vision for people with retinal degeneration using optogenetics gene therapies. Ray Therapeutics is pursuing multiple drug development programs for a range of degenerative retinal diseases, focusing on preserving and restoring vision in patients using the ground-breaking science of optogenetics. The company was founded by Paul Bresge and Sean Ainsworth, with Paul Bresge serving as CEO since incorporation. | 9 years |
| Richard Rodgers | M | 57 | 4 years | |
| Matthew Scholz | M | - |
Immusoft Corp.
Immusoft Corp. Medical/Nursing ServicesHealth Services Immusoft Corp. provides disease curing services through immune cells. The firm offers ISP, gene delivery technology and lymphopoiesis culture system. The company was founded by Matthew Scholz in 2009 and is headquartered in Seattle, WA. | 15 years |
| Amy Rabourn | F | 44 | 5 years | |
| Dmitry Kuzmin | M | - |
RetroSense Therapeutics LLC
RetroSense Therapeutics LLC Medical SpecialtiesHealth Technology RetroSense Therapeutics LLC provides biotechnology services. It offers gene therapies to restore vision in patients suffering from blindness due to retinitis pigmentosa and advanced dry age-related macular degeneration. The company was founded by Sean Ainsworth in 2009 and is headquartered in Ann Arbor, MI.
Ray Therapeutics, Inc.
Ray Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Ray Therapeutics, Inc. is an American company that is developing a lead candidate, RTX-015, to treat retinitis pigmentosa, a degenerative retinal disease. Ray Therapeutics is based in an undisclosed location. The company's mission is to restore vision for people with retinal degeneration using optogenetics gene therapies. Ray Therapeutics is pursuing multiple drug development programs for a range of degenerative retinal diseases, focusing on preserving and restoring vision in patients using the ground-breaking science of optogenetics. The company was founded by Paul Bresge and Sean Ainsworth, with Paul Bresge serving as CEO since incorporation. | 1 years |
| Paul Bresge | M | - |
Ray Therapeutics, Inc.
Ray Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Ray Therapeutics, Inc. is an American company that is developing a lead candidate, RTX-015, to treat retinitis pigmentosa, a degenerative retinal disease. Ray Therapeutics is based in an undisclosed location. The company's mission is to restore vision for people with retinal degeneration using optogenetics gene therapies. Ray Therapeutics is pursuing multiple drug development programs for a range of degenerative retinal diseases, focusing on preserving and restoring vision in patients using the ground-breaking science of optogenetics. The company was founded by Paul Bresge and Sean Ainsworth, with Paul Bresge serving as CEO since incorporation. | - |
| Bernhard Hoffmann | M | 68 | 6 years | |
| George Magrath | M | 40 | 1 years | |
| Erik Sims | M | - | 3 years | |
| Jay Pepose | M | 69 | 3 years | |
| Susan Benton | F | 59 | 4 years | |
| Gary Abrams | M | - |
Ray Therapeutics, Inc.
Ray Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Ray Therapeutics, Inc. is an American company that is developing a lead candidate, RTX-015, to treat retinitis pigmentosa, a degenerative retinal disease. Ray Therapeutics is based in an undisclosed location. The company's mission is to restore vision for people with retinal degeneration using optogenetics gene therapies. Ray Therapeutics is pursuing multiple drug development programs for a range of degenerative retinal diseases, focusing on preserving and restoring vision in patients using the ground-breaking science of optogenetics. The company was founded by Paul Bresge and Sean Ainsworth, with Paul Bresge serving as CEO since incorporation. | - |
| James Manuso | M | 75 | 5 years | |
| Ronil Patel | M | - | 3 years | |
| Drey Coleman | F | - | - | |
| Terry O’Neal | M | - |
Ray Therapeutics, Inc.
Ray Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Ray Therapeutics, Inc. is an American company that is developing a lead candidate, RTX-015, to treat retinitis pigmentosa, a degenerative retinal disease. Ray Therapeutics is based in an undisclosed location. The company's mission is to restore vision for people with retinal degeneration using optogenetics gene therapies. Ray Therapeutics is pursuing multiple drug development programs for a range of degenerative retinal diseases, focusing on preserving and restoring vision in patients using the ground-breaking science of optogenetics. The company was founded by Paul Bresge and Sean Ainsworth, with Paul Bresge serving as CEO since incorporation. | - |
| Richard Feinberg | M | 76 |
University of California San Diego
| 28 years |
| Barbara Withers | F | - | - | |
| Raymond Camahort | M | 45 |
Ray Therapeutics, Inc.
Ray Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Ray Therapeutics, Inc. is an American company that is developing a lead candidate, RTX-015, to treat retinitis pigmentosa, a degenerative retinal disease. Ray Therapeutics is based in an undisclosed location. The company's mission is to restore vision for people with retinal degeneration using optogenetics gene therapies. Ray Therapeutics is pursuing multiple drug development programs for a range of degenerative retinal diseases, focusing on preserving and restoring vision in patients using the ground-breaking science of optogenetics. The company was founded by Paul Bresge and Sean Ainsworth, with Paul Bresge serving as CEO since incorporation. | - |
| Ziad Henry Moukheiber | M | - |
RetroSense Therapeutics LLC
RetroSense Therapeutics LLC Medical SpecialtiesHealth Technology RetroSense Therapeutics LLC provides biotechnology services. It offers gene therapies to restore vision in patients suffering from blindness due to retinitis pigmentosa and advanced dry age-related macular degeneration. The company was founded by Sean Ainsworth in 2009 and is headquartered in Ann Arbor, MI. | 9 years |
| Joseph Schachle | M | 59 | 1 years | |
| Hannah Chang | M | - |
Ray Therapeutics, Inc.
Ray Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Ray Therapeutics, Inc. is an American company that is developing a lead candidate, RTX-015, to treat retinitis pigmentosa, a degenerative retinal disease. Ray Therapeutics is based in an undisclosed location. The company's mission is to restore vision for people with retinal degeneration using optogenetics gene therapies. Ray Therapeutics is pursuing multiple drug development programs for a range of degenerative retinal diseases, focusing on preserving and restoring vision in patients using the ground-breaking science of optogenetics. The company was founded by Paul Bresge and Sean Ainsworth, with Paul Bresge serving as CEO since incorporation. | - |
| William Hyun | M | - |
Immusoft Corp.
Immusoft Corp. Medical/Nursing ServicesHealth Services Immusoft Corp. provides disease curing services through immune cells. The firm offers ISP, gene delivery technology and lymphopoiesis culture system. The company was founded by Matthew Scholz in 2009 and is headquartered in Seattle, WA. | 11 years |
| Alexey Konov | M | - |
RetroSense Therapeutics LLC
RetroSense Therapeutics LLC Medical SpecialtiesHealth Technology RetroSense Therapeutics LLC provides biotechnology services. It offers gene therapies to restore vision in patients suffering from blindness due to retinitis pigmentosa and advanced dry age-related macular degeneration. The company was founded by Sean Ainsworth in 2009 and is headquartered in Ann Arbor, MI. | - |
| Mark J. Ahn | M | 61 |
Immusoft Corp.
Immusoft Corp. Medical/Nursing ServicesHealth Services Immusoft Corp. provides disease curing services through immune cells. The firm offers ISP, gene delivery technology and lymphopoiesis culture system. The company was founded by Matthew Scholz in 2009 and is headquartered in Seattle, WA. | - |
| Mitchell Brigell | M | - | - | |
| Kenneth Kousky | M | 70 |
RetroSense Therapeutics LLC
RetroSense Therapeutics LLC Medical SpecialtiesHealth Technology RetroSense Therapeutics LLC provides biotechnology services. It offers gene therapies to restore vision in patients suffering from blindness due to retinitis pigmentosa and advanced dry age-related macular degeneration. The company was founded by Sean Ainsworth in 2009 and is headquartered in Ann Arbor, MI. | - |
| Terry Cross | M | 84 |
RetroSense Therapeutics LLC
RetroSense Therapeutics LLC Medical SpecialtiesHealth Technology RetroSense Therapeutics LLC provides biotechnology services. It offers gene therapies to restore vision in patients suffering from blindness due to retinitis pigmentosa and advanced dry age-related macular degeneration. The company was founded by Sean Ainsworth in 2009 and is headquartered in Ann Arbor, MI. | - |
| Nirav Jhaveri | M | 46 | - | |
| Amy Caterina | F | - |
RetroSense Therapeutics LLC
RetroSense Therapeutics LLC Medical SpecialtiesHealth Technology RetroSense Therapeutics LLC provides biotechnology services. It offers gene therapies to restore vision in patients suffering from blindness due to retinitis pigmentosa and advanced dry age-related macular degeneration. The company was founded by Sean Ainsworth in 2009 and is headquartered in Ann Arbor, MI. | - |
| Tiba Aynechi | M | 48 |
Ray Therapeutics, Inc.
Ray Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Ray Therapeutics, Inc. is an American company that is developing a lead candidate, RTX-015, to treat retinitis pigmentosa, a degenerative retinal disease. Ray Therapeutics is based in an undisclosed location. The company's mission is to restore vision for people with retinal degeneration using optogenetics gene therapies. Ray Therapeutics is pursuing multiple drug development programs for a range of degenerative retinal diseases, focusing on preserving and restoring vision in patients using the ground-breaking science of optogenetics. The company was founded by Paul Bresge and Sean Ainsworth, with Paul Bresge serving as CEO since incorporation. | 1 years |
| Tony Chou | M | 63 |
University of California San Diego
| 30 years |
| Tony Sun | M | 52 |
Immusoft Corp.
Immusoft Corp. Medical/Nursing ServicesHealth Services Immusoft Corp. provides disease curing services through immune cells. The firm offers ISP, gene delivery technology and lymphopoiesis culture system. The company was founded by Matthew Scholz in 2009 and is headquartered in Seattle, WA. | 6 years |
| Julia Moore | F | - |
Immusoft Corp.
Immusoft Corp. Medical/Nursing ServicesHealth Services Immusoft Corp. provides disease curing services through immune cells. The firm offers ISP, gene delivery technology and lymphopoiesis culture system. The company was founded by Matthew Scholz in 2009 and is headquartered in Seattle, WA. | 6 years |
| Lin-Tsing Yu | M | 80 |
University of California San Diego
| 30 years |
| Ash Jayagopal | M | - | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Mina Sooch | F | 56 | 5 years | |
| Alan R. Meyer | M | - | 3 years | |
| Dan Mytels | M | - |
University of California San Diego
| 5 years |
| Carolyn J. Otten | M | - |
Washington University in St. Louis
| 5 years |
| Tim Laczkowski | M | - |
Washington University in St. Louis
| 12 years |
| Sean Fitzgerald | M | - |
Washington University in St. Louis
| 5 years |
| Bob Whiton | M | - |
University of California San Diego
| 5 years |
| Gregory Mayhew | M | - |
Washington University in St. Louis
| 2 years |
| Tony Craddock | M | - |
University of California San Diego
| 8 years |
| Bjorn Markus Jakobsson | M | - |
University of California San Diego
| 3 years |
| Alipour Navid | M | - |
University of California San Diego
| 4 years |
| Stephen Ritter | M | 54 |
University of California San Diego
| 4 years |
| Ophir Gottlieb | M | - |
University of California San Diego
| 4 years |
| Bryan Hall | M | - |
University of California San Diego
| 4 years |
| Jason Childers | M | - |
University of California San Diego
| 4 years |
| Gary Kliegman | M | - |
Washington University in St. Louis
| 4 years |
| Derek A. Gluckman | M | - |
Washington University in St. Louis
| 4 years |
| Michael Cheung | M | - |
Washington University in St. Louis
| 4 years |
| Lana Alamat | F | - |
Washington University in St. Louis
| 3 years |
| Darren Weiss | M | 40 |
Washington University in St. Louis
| 4 years |
| Vikram Grover | M | 54 |
University of California San Diego
| 4 years |
| Thomas Castleberry | M | - |
University of California San Diego
| 4 years |
| Edmondo Robinson | M | - |
University of California San Diego
| 4 years |
| Neng Wang | M | 50 |
University of California San Diego
| 1 years |
| Anthony Gino Valeri | M | 54 |
University of California San Diego
| 4 years |
| Jonah Glick | M | - |
Washington University in St. Louis
| 4 years |
| Robert Plenge | M | 53 |
University of California San Diego
| 4 years |
| Allison Hushek | F | - |
University of California San Diego
| 4 years |
| Bradley Ottinger | M | 54 |
Washington University in St. Louis
| 3 years |
| Yang Xie | M | 54 |
Washington University in St. Louis
| 2 years |
| Rebecca Jonah | F | - |
University of California San Diego
| 4 years |
| Jonathan Lang | M | - |
University of California San Diego
| 5 years |
| Jeffery A. Jones | M | - |
University of California San Diego
| 4 years |
| Greg Little | M | - |
University of California San Diego
| 5 years |
| Jeff Schlosser | M | - |
University of California San Diego
| 4 years |
| Paul A. Dixon | M | - |
University of California San Diego
| 3 years |
| Joncarlo Mark | M | - |
University of California San Diego
| 5 years |
| Jason Maxwell | M | - |
University of California San Diego
| 4 years |
| Josh Moss | M | - |
University of California San Diego
| 3 years |
| Dean Lyulkin | M | - |
University of California San Diego
| 4 years |
| Vikram K. Srimurthy | M | - |
University of California San Diego
| 4 years |
| Michael G. Chandra | M | - |
Washington University in St. Louis
| 4 years |
| Brian D. Fox | M | 78 |
University of California San Diego
| 4 years |
| Dan Molina | M | - |
University of California San Diego
| 4 years |
| Alex J. Rigolizzo | M | - |
University of California San Diego
| 4 years |
| Jake Rothman | M | - |
University of California San Diego
| 4 years |
| Eric Richard Bertrand | M | - |
University of California San Diego
| 4 years |
| Tavi Yehudai | M | - |
Washington University in St. Louis
| 3 years |
| Gregory R. Woodhill | M | - |
University of California San Diego
| 4 years |
| Kenneth M. Salinger | M | - |
University of California San Diego
| 4 years |
| Daniel McMahon | M | 52 |
University of California San Diego
| 4 years |
| Richard L. Sowers | M | 51 |
University of California San Diego
| 4 years |
| Kenneth T. Shimizu | M | - |
University of California San Diego
| 13 years |
| Joe Riehl | M | - |
University of California San Diego
| 4 years |
| Travis Rouillard | M | - |
University of California San Diego
| 4 years |
| Greg Young | M | - |
University of California San Diego
| 4 years |
| Jeff Stone | M | - |
University of California San Diego
| 4 years |
| Tad Gallistel | M | - |
University of California San Diego
| 4 years |
| Christie M. Whitney | F | - |
University of California San Diego
| 4 years |
| Ed Wagner | M | - |
University of California San Diego
| 5 years |
| F. Mitchell Thrower | M | - |
University of California San Diego
| 2 years |
| Blair Harrison Wallace | M | - |
University of California San Diego
| - |
| David B. Fogel | M | - |
University of California San Diego
| 3 years |
| Shyam Srinivas | M | - |
Washington University in St. Louis
| 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Sean Ainsworth
- Personal Network
